| SNBP Shares Outstanding History Table | ||||||||
Below is a table of the SNBP shares outstanding history going back to 8/7/2020:
Also see: SNBP Market Cap History SNBP YTD Return |
SNBP Shares Outstanding History — Sun BioPharma Share Count Over Time
As of 11/11/2020 Sun BioPharma has 9.65 million SNBP shares outstanding. Investors often track the SNBP shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SNBP share count trends over time, with 3 historical shares outstanding datapoints presented, dating back to 8/7/2020.
| SNBP Shares Outstanding History Chart | |||||||||
SNBP Historical Shares Outstanding: +138.84% CAGR 
Mouse over chart for data details
| |||||||||
| SNBP Stock Price Chart |
| About Panbela Therapeutics Inc |
| Sun BioPharma is engaged in advancing the commercial development of a proprietary polyamine analogue for pancreatic cancer. Co. has exclusively licensed the worldwide rights to this compound, which has been designated as SBP-101, from the University of Florida Research Foundation, Inc. Co.'s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition, a metabolic pathway of critical importance in multiple tumor types. We show 3 historical shares outstanding datapoints in our coverage of SNBP's shares outstanding history. Understanding the changing numbers of SNBP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SNBP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SNBP by allowing them to research SNBP shares outstanding history as well as any other stock in our coverage universe. |
| SNBP Current Stock Quote |
Quotes delayed 20 minutes  Free SNBP Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SNBP Share Performance |
| Shares Outstanding Peers |
| Sun BioPharma (SNBP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SNCA Shares Outstanding History SNDA Shares Outstanding History SNDX Shares Outstanding History SNES Shares Outstanding History SNGX Shares Outstanding History SNNA Shares Outstanding History SNOA Shares Outstanding History SNPX Shares Outstanding History SNSE Shares Outstanding History SNSS Shares Outstanding History More Healthcare companies » |
SNBP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
